Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Tadashi Kondo"'
Autor:
Setsuo Hirohashi, Shoji Kudoh, Harbumi Kato, Akihiko Gemma, Yoshihiro Matsuno, Koji Tsuta, Yuichiro Ohe, Toshimi Takano, Toshihide Nishimura, Kiyonaga Fujii, Tadashi Kondo, Tetsuya Okano
Supplementary Figure 2 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3473b32464825b5041bc3c4dfac2d2a7
https://doi.org/10.1158/1078-0432.22441915
https://doi.org/10.1158/1078-0432.22441915
Autor:
Jia Fan, Tadashi Kondo, Yifeng He, Yuan Ji, Ming Kuang, Jian Zhou, Chengyu Gu, Guangyu Ding, Cheng Huang
PDF file - 153K, Clinical characteristics of the 323 HCC Patients used in cohort 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5d9d53acc65e0bf55072ce4971297c1
https://doi.org/10.1158/1078-0432.22445726
https://doi.org/10.1158/1078-0432.22445726
Autor:
Jia Fan, Tadashi Kondo, Yifeng He, Yuan Ji, Ming Kuang, Jian Zhou, Chengyu Gu, Guangyu Ding, Cheng Huang
PDF file - 73K, Supplemental Figure S1: The relationship of SBP1 Expression level and Prognosis. The expression levels of SBP1 in 323 HCC tissues were divided by a 4-point scale (0 - +++) system based on the number of positive cells and the intensity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e7e71ea56f50340b1ab7bc52427d9b5
https://doi.org/10.1158/1078-0432.22445732
https://doi.org/10.1158/1078-0432.22445732
Autor:
Jia Fan, Tadashi Kondo, Yifeng He, Yuan Ji, Ming Kuang, Jian Zhou, Chengyu Gu, Guangyu Ding, Cheng Huang
PDF file - 129K, Multivariate analyses of factors associated with survival and recurrence in cohort 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3af008167139359d741fdd5cd9e24376
https://doi.org/10.1158/1078-0432.22445720
https://doi.org/10.1158/1078-0432.22445720
Autor:
Setsuo Hirohashi, Shoji Kudoh, Harbumi Kato, Akihiko Gemma, Yoshihiro Matsuno, Koji Tsuta, Yuichiro Ohe, Toshimi Takano, Toshihide Nishimura, Kiyonaga Fujii, Tadashi Kondo, Tetsuya Okano
Supplementary Figure 4 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44e22ecdcf945daf991dce1518225fc4
https://doi.org/10.1158/1078-0432.22441909
https://doi.org/10.1158/1078-0432.22441909
Autor:
Setsuo Hirohashi, Shoji Kudoh, Harbumi Kato, Akihiko Gemma, Yoshihiro Matsuno, Koji Tsuta, Yuichiro Ohe, Toshimi Takano, Toshihide Nishimura, Kiyonaga Fujii, Tadashi Kondo, Tetsuya Okano
Supplementary Text from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92b0d1ad843a027707d18818481d15e9
https://doi.org/10.1158/1078-0432.22441885
https://doi.org/10.1158/1078-0432.22441885
Autor:
Setsuo Hirohashi, Shoji Kudoh, Harbumi Kato, Akihiko Gemma, Yoshihiro Matsuno, Koji Tsuta, Yuichiro Ohe, Toshimi Takano, Toshihide Nishimura, Kiyonaga Fujii, Tadashi Kondo, Tetsuya Okano
Supplementary Figure 3 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3959385d2ca1884dcbd6ae659907290e
https://doi.org/10.1158/1078-0432.22441912.v1
https://doi.org/10.1158/1078-0432.22441912.v1
Autor:
Jia Fan, Tadashi Kondo, Yifeng He, Yuan Ji, Ming Kuang, Jian Zhou, Chengyu Gu, Guangyu Ding, Cheng Huang
Purpose: We aimed to characterize the role of selenium-binding protein 1 (SBP1) in hepatocellular carcinoma (HCC) invasiveness and underlying clinical significance.Experimental Design: SBP1 expression was measured in stepwise metastatic HCC cell line
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e5cccb0a68694afbbfb0c75c215284a
https://doi.org/10.1158/1078-0432.c.6520550.v1
https://doi.org/10.1158/1078-0432.c.6520550.v1
Autor:
Setsuo Hirohashi, Shoji Kudoh, Harbumi Kato, Akihiko Gemma, Yoshihiro Matsuno, Koji Tsuta, Yuichiro Ohe, Toshimi Takano, Toshihide Nishimura, Kiyonaga Fujii, Tadashi Kondo, Tetsuya Okano
Supplementary Figure 1 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1869d508d425cb74584286b2b83e743e
https://doi.org/10.1158/1078-0432.22441918
https://doi.org/10.1158/1078-0432.22441918